SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 198 filers reported holding SEATTLE GENETICS INC in Q3 2013. The put-call ratio across all filers is 2.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $169,571,000 | +79886.3% | 866,529 | +72110.8% | 0.08% | – |
| Q2 2020 | $212,000 | -98.2% | 1,200 | -99.3% | 0.00% | -100.0% |
| Q1 2019 | $11,967,000 | +29.3% | 163,400 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $9,258,000 | -26.5% | 163,400 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $12,601,000 | +75.1% | 163,400 | +50.7% | 0.01% | +50.0% |
| Q2 2018 | $7,197,000 | +26.8% | 108,400 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $5,674,000 | +3.6% | 108,400 | +5.9% | 0.00% | 0.0% |
| Q4 2017 | $5,478,000 | +25.8% | 102,400 | +28.0% | 0.00% | +50.0% |
| Q3 2017 | $4,353,000 | +88.7% | 80,000 | +118.0% | 0.00% | +100.0% |
| Q1 2017 | $2,307,000 | -80.9% | 36,699 | -86.7% | 0.00% | -83.3% |
| Q3 2013 | $12,054,000 | +25.0% | 275,030 | -10.3% | 0.01% | 0.0% |
| Q2 2013 | $9,644,000 | – | 306,530 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
| Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
| Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
| Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
| NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
| Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
| WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
| Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
| CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
| Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |